Sort
25,944 grants matching “neurodegeneration”
Targeting Cardiovascular Disease with SIRT6 Activators
$228,750Raphael M. Franzini · University Of Utah · R21 · FY2022 · AG
Interactions of Perirhinal Tau Pathology and Aging in Cognitive Dysfunction
$228,750Jennifer Lynn Bizon · University Of Florida · R21 · FY2019 · AG
TEMPLATED CONVERSION OF TRANSMISSIBLE PROTEINS IN NEUROMUSCULAR DISEASE
$228,750Conrad C Weihl · Washington University · R21 · FY2018 · NS
Pathological spread and outcomes of alpha-synuclein mutants
$228,750Benoit I Giasson · University Of Florida · R21 · FY2018 · NS
Uncovering targets that block pathological interactions between Abeta and tau
$228,750Diego E Rincon-Limas · University Of Florida · R21 · FY2017 · AG
Analysis of adaptive responses of astrocytes
$228,750Tomasz K Kordula · Virginia Commonwealth University · R21 · FY2018 · NS
HtrA2-mediated RIP1 cleavage regulates neuronal inflammation and death
$228,750Hasem Habelhah · University Of Iowa · R21 · FY2017 · NS
CLINICAL TRIAL OF DANTROLENE SODIUM IN PATIENTS WITH WOLFRAM SYNDROME
$228,750Fumihiko Urano · Washington University · R21 · FY2017 · DK
Crosslinking Action of Chlorpyrifos Oxon as Mechanism of Chronic Illness
$228,750Oksana Lockridge · University Of Nebraska Medical Center · R21 · FY2021 · ES
Characterization of ATXN2 as a target for ALS in SCA2 motor neurons
$228,750Stefan M. Pulst · University Of Utah · R21 · FY2019 · NS
Discovery and evaluation of novel therapy for Niemann-Pick type C targeting NPC1
$228,750Sarah Spiegel · Virginia Commonwealth University · R21 · FY2014 · NS
Animal model of impaired autoregulation for study of age related vascular cognitive impairment
$228,750Fan Fan · University Of Mississippi Med Ctr · R21 · FY2017 · AG
Schlemmâs canal targeted-Tie2 knockdown as a mouse model of adult-onset ocular hypertension and glaucoma
$228,750Alejandra Bosco · University Of Utah · R21 · FY2021 · EY
EPIGENETIC AND MRNA PROFILING OF STRIATOPALLIDAL NEURONS IN HUNTINGTON'S DISEASE
$228,750Hiroko Yano · Washington University · R21 · FY2017 · NS
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease
$228,711Bahareh Behrouz · Vincere Biosciences, Inc. · R43 · FY2024 · NS
Alcohol and traumatic brain injury; neuronal and behavioral consequences
$228,688Patricia E Molina · Lsu Health Sciences Center · R01 · FY2020 · AA
FUNCTION OF THE ATAXIA TELANGIECTASIA GENE PRODUCT
$228,637Immune Disease Institute, Inc. · R01 · FY2000 · GM
GENETIC CONTROL OF NEUROMUSCULAR DEGENERATION IN MICE
$228,611Jackson Laboratory · R01 · FY2001 · NS
Spasticity and Upper Motor Neuron Disorders
$228,578Mary Kay Floeter · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
A research and clinical tool for connectivity-based analysis of brainstem anatomy
$228,571Sarah H Ying · Johns Hopkins University · R21 · FY2008 · NS
Presenilin Function and Calcium Regulation in Alzheimers Disease
$228,564University Of California Irvine · P50 · FY2002 · AG
Complement and Inflammation in Pathogenesis of Dementia
$228,564University Of California Irvine · P50 · FY2002 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION
$228,404University Of Kentucky · P01 · FY2000 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION
$228,404University Of Kentucky · P01 · FY2001 · AG
MRI Assessment--Transgenic Models of Alzheimer's Disease
$228,401Nathan S. Kline Institute For Psych Res · P01 · FY2000 · AG